I read George Will’s hand-wringing column about the imminent demise of Medicare (2/7, Opinion, “Obama willing, Congress weak on entitlements”). Maybe if our government were willing to curb corporate welfare for the prescription drug companies, we could save a few billion.
I was shocked to find that my Medicare Plan D cost for one of my prescriptions, for both my co-pay and Medicare, was $392 for a 90-day supply, and another was $265 for 90 days. I checked prices at a Canadian pharmacy and found their price was $110 for the former and $200 for the latter for the same product.
I have heard all the special pleading from pharmaceutical companies about the cost of research being high. But does this mean that the U.S. is footing the bill for it while other countries regulate prices? Maybe, but I think we have a case of what Will euphemizes as “political free speech”— i.e. bribery of Congress.
Drug companies enjoy a monopoly on patented prescription drugs. We should regulate their prices.
Carrol L. Fry